📘 FDA manuals • Free online PDFs
Aami FDA

Àwọn Ìwé Àfọwọ́kọ FDA àti Ìtọ́sọ́nà Olùlò

The U.S. Food and Drug Administration (FDA) is the federal agency responsible for protecting public health by regulating food, drugs, medical devices, cosmetics, and more.

Àmọ̀ràn: fi gbogbo nọ́mbà àwòṣe tí a tẹ̀ sórí àmì FDA rẹ kún un fún ìbáramu tí ó dára jùlọ.

About FDA manuals on Manuals.plus

Awọn U.S. Food and Drug Administration (FDA) is a federal agency of the Department of Health and Human Services. It is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods and feed, and veterinary products.

This directory serves as a resource for user manuals related to FDA systems (such as the Electronic Submission Gateway), regulatory guidelines, and official prescribing information (package inserts) for FDA-approved medical products.

Àwọn ìwé ìtọ́ni FDA

Titun Afowoyi lati manuals+ curated fun yi brand.

FDA Mayzent Siponimod Tablets Owner’s Manual

Oṣu Kẹjọ Ọjọ 17, Ọdun 2026
FDA Mayzent Siponimod Tablets Overview MAYZENT (siponimod) is an oral S1P receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome,…

FDA Sotyktu Deucravacitinib Tablets Owner’s Manual

Oṣu Kẹjọ Ọjọ 17, Ọdun 2026
FDA Sotyktu Deucravacitinib Tablets Overview SOTYKTU (deucravacitinib) is an oral TYK2 inhibitor indicated for moderate-to-severe plaque psoriasis and active psoriatic arthritis in adults, with a recommended dose of 6 mg…

FDA Anzupgo Delgocitinib Cream Owner’s Manual

Oṣu Kẹjọ Ọjọ 17, Ọdun 2026
FDA Anzupgo Delgocitinib Cream Overview ANZUPGO (delgocitinib) cream is a topical JAK inhibitor indicated for the treatment of moderate to severe chronic hand eczema (CHE) in adults who have had…

FDA Alectinib Capsules Owner’s Manual

Oṣu Kẹjọ Ọjọ 16, Ọdun 2026
FDA Alectinib Capsules Overview ALECENSA is a kinase inhibitor indicated for ALK-positive NSCLC, used either as adjuvant treatment after tumor resection (in adults) or for treatment of adult metastatic ALK-positive…

FDA 2BVLC-PREX Laser Engraver Instruction Manual

Oṣu Karun ọjọ 19, Ọdun 2026
FDA 2BVLC-PREX Laser Engraver FCC Requirement Any changes or modifications not expressly approved by the party responsible for compliance could void the user’s authority to operate the equipment. This device…

FDA ESG NEXTGEN App olumulo Itọsọna

Oṣu Kẹrin Ọjọ 5, Ọdun 2025
FDA Electronic Submission Gateway (ESG) NextGen API Guide FDA Electronic Submission Gateway (ESG) NextGen API Guide Application Program Interface Version 1.0 March 2025 1. Introduction This document provides guidelines for…

General Instructions for Form FDA 3500A MedWatch

itọnisọna
Comprehensive instructions for completing the FDA Form 3500A MedWatch for mandatory adverse event reporting, including sections for patient information, product problems, and device-specific reporting.

CFSAN Online Submission Module (COSM) Quick Start Guide

Quick Bẹrẹ Itọsọna
A quick start guide for using the CFSAN Online Submission Module (COSM) to submit regulatory documents to the U.S. Food and Drug Administration (FDA), covering registration, login, contact management, submission…

Ìtọ́sọ́nà àti Ìṣàkóso Àwọn Èèjà Ẹja àti Ipeja - Ẹ̀dà Kẹrin

Itọsọna
Ìtọ́sọ́nà fún ilé iṣẹ́ ẹja àti ọjà ẹja lórí ṣíṣe àgbékalẹ̀ àwọn ètò HACCP, dídá àwọn ewu (ẹ̀dá alààyè, kẹ́míkà, ti ara), àti ṣíṣe àwọn ọgbọ́n ìṣàkóso fún ààbò ẹja, bíbo àwọn àkóràn, àwọn majele, àwọn ohun tí ń fa àléjì, àti àwọn ohun tí ó lè ba àléjì jẹ́.

Ètò Ìṣàkóso àti Àwọn Ìlànà FDA Fọ́ọ̀mù

Oṣiṣẹ Afowoyi Itọsọna
Ìlànà àti ìlànà láti ọ̀dọ̀ Food and Drug Administration (FDA) tí ó ṣàlàyé ìdàgbàsókè, ìṣàkóso, àti ìgbésí ayé àwọn fọ́ọ̀mù aṣojú, títí kan àwọn ìtẹ̀wé àti àwọn ẹ̀rọ itanna, tí ó ń rí i dájú pé ó bá ìlànà mu àti pé ó ṣiṣẹ́ dáadáa.

FDA support FAQ

Awọn ibeere ti o wọpọ nipa awọn itọnisọna, iforukọsilẹ, ati atilẹyin fun ami iyasọtọ yii.

  • What is the FDA Electronic Submission Gateway (ESG)?

    The FDA ESG is an agency-wide solution for accepting electronic regulatory submissions. It enables the secure submission of regulatory information for review by the agency.

  • How do I report a problem with a medical device or drug?

    You can report adverse events or quality problems with FDA-regulated products through the MedWatch program online at www.fda.gov/medwatch or by calling 1-800-FDA-1088.

  • Where can I find prescribing information for FDA-approved drugs?

    Prescribing information (package inserts) is available on the FDA website via the Drugs@FDA database. Many of these documents are also archived here for easy reference.

  • Does the FDA provide warranties for medical products?

    No, the FDA regulates the safety and efficacy of products but does not manufacture or warranty them. Warranty claims should be directed to the specific product manufacturer.